Myélopathies inflammatoires : de la SEP à la NMO

Scott, 2007, Nosology of idiopathic transverse myelitis syndromes, Acta Neurol Scand, 115, 371, 10.1111/j.1600-0404.2007.00835.x Transverse Myelitis Consortium, 2002, Proposed diagnostic criteria and nosology of acute transverse myelitis, Neurology, 59, 499, 10.1212/WNL.59.4.499 Wingerchuk, 2006, Revised diagnostic criteria for neuromyelitis optica, Neurology, 66, 1485, 10.1212/01.wnl.0000216139.44259.74 Wingerchuk, 1999, The clinical course of neuromyelitis optica (Devic's syndrome), Neurology, 53, 1107, 10.1212/WNL.53.5.1107 Miller, 2008, Differential diagnosis of suspected multiple sclerosis: a consensus approach, Mult Scler, 14, 1157, 10.1177/1352458508096878 Wingerchuk, 2015, International consensus diagnostic criteria for neuromyelitis optica spectrum disorders, Neurology, 85, 177, 10.1212/WNL.0000000000001729 Jacobs, 2000, Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS, J Med, 343, 898 Kappos, 2007, Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study, Lancet, 370, 389, 10.1016/S0140-6736(07)61194-5 de Seze, 2005, Idiopathic acute transverse myelitis: application of the recent diagnostic criteria, Neurology, 65, 1950, 10.1212/01.wnl.0000188896.48308.26 Bigaut, 2021, Atypical myelitis in patients with multiple sclerosis: Characterization and comparison with typical multiple sclerosis and neuromyelitis optica spectrum disorders, Mult Scler, 27, 232, 10.1177/1352458520906995 Lennon, 2005, IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel, J Exp Med, 202, 473, 10.1084/jem.20050304 Lennon, 2004, A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis, Lancet, 364, 2106, 10.1016/S0140-6736(04)17551-X Kitley, 2012, Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype, Neurology, 79, 1273, 10.1212/WNL.0b013e31826aac4e Sato, 2014, Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders, Neurology, 82, 474, 10.1212/WNL.0000000000000101 Pekcevik, 2015, Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging, Mult Scler Ortega, 2013, NMO spectrum presenting as partial myelitis, Mult Scler, 19, 252, 10.1177/1352458512445303 Collongues, 2011, Current and future treatment approaches for neuromyelitis optica, Ther Adv Neurol Disord, 4, 111, 10.1177/1756285611398939